BTG Specialty Pharmaceuticals
Conshohocken
About BTG Specialty Pharmaceuticals
The BTG Specialty Pharmaceuticals business develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Website: btgsp.comen-us
Social Profiles
Canonical: https://fsome.com/organization/btg-specialty-pharmaceuticals-3085520 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.